Moreover, the combination of gemcitabine with ferroptosis inducers has demonstrated an enhancement of cytotoxic effects in SMAD4-positive organoids, proposing a viable combination therapy for pancreatic cancer [56]. Here, SMAD4 is linked to pancreatic neoplasm.